UltraSight announced a partnership with SELVAS Healthcare. This new joint venture kicks off the introduction of UltraSight's real-time AI guidance technology in Asia, beginning with the regulatory process for approvals that may lead to eventual commercialization and distribution in Korea and the Southeast Asian market. UltraSight's software pairs with point-of-care ultrasound (POCUS) devices to provide medical professionals with real-time guidance to acquire diagnostic-quality cardiac ultrasound images, regardless of experience level.

SELVAS Healthcare will have exclusive rights to distribute and commercialize UltraSight's AI cardiac ultrasound technology in Korea.